跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GD-20
首页
药物
GD-20
GD-20
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Graphene quantum dots-gadolinium ion chelate as magnetic resonance imaging contrast agent and preparation method thereof
申请人: UNIV ANHUI
优先权: 2019
US
Dimerization gadolinium-based T1 magnetic resonance contrast agent as well as preparation method and application thereof
申请人: ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY
优先权: 2022
CN
Preparation method and application of x-ray activatable nanoparticles
申请人: UNIV PEKING SHENZHEN HOSPITAL
优先权: 2024
CN
Traditional Chinese medicine compound preparation for treating Graves disease
申请人: UNIV LIAONING TRADITIONAL CHINESE MEDICINE
优先权: 2020
CN
Anti-pseudorabies virus circular RNA vaccine and preparation method thereof
申请人: SHANGHAI SHENRUILIAN BIOMEDICAL CO LTD
优先权: 2023
CN
Preparation method of targeted fibroblast activation protein MR liposome probe
申请人: FIRST HOSPITAL LANZHOU UNIV
优先权: 2024
CN
Fe3O4/DOPA/(Gd/DTPA) nano material, and preparation method and application of material
申请人: UNIV SHANGHAI
优先权: 2013
CN
New use of l-histidine and derivatives thereof
申请人: BRACCO IMAGING SPA
优先权: 2011
EP
药物
反馈